Article By:
Invezz
Wednesday, September 27, 2023 4:05 AM EDT
Roivant Sciences has 12 drugs in its pipeline. The company’s Immunovant subsidiary reported strong results for its drug. Roivant is in talks with Roche to sell its Chron’s disease for $7 billion.
In this article: ROIV Also: IMVT
